IS8547A - Samsett lyfjablanda til að hamla gegn hrörnun vitsmunastarfsemi - Google Patents

Samsett lyfjablanda til að hamla gegn hrörnun vitsmunastarfsemi

Info

Publication number
IS8547A
IS8547A IS8547A IS8547A IS8547A IS 8547 A IS8547 A IS 8547A IS 8547 A IS8547 A IS 8547A IS 8547 A IS8547 A IS 8547A IS 8547 A IS8547 A IS 8547A
Authority
IS
Iceland
Prior art keywords
combination drug
cognitive degeneration
inhibit cognitive
inhibit
degeneration
Prior art date
Application number
IS8547A
Other languages
English (en)
Inventor
Lévay György
Gacsßlyi Istvßn
Gábor Hársing László
Simig Gyula
Original Assignee
Egis Gyógyszergyár Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyógyszergyár Nyrt. filed Critical Egis Gyógyszergyár Nyrt.
Publication of IS8547A publication Critical patent/IS8547A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8547A 2004-03-12 2006-10-03 Samsett lyfjablanda til að hamla gegn hrörnun vitsmunastarfsemi IS8547A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU2004/000022 WO2005087212A1 (en) 2004-03-12 2004-03-12 Combined pharmaceutical composition for the inhibition of the decline of cognitive functions

Publications (1)

Publication Number Publication Date
IS8547A true IS8547A (is) 2006-10-03

Family

ID=34957271

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8547A IS8547A (is) 2004-03-12 2006-10-03 Samsett lyfjablanda til að hamla gegn hrörnun vitsmunastarfsemi

Country Status (17)

Country Link
US (1) US20080021016A1 (is)
EP (1) EP1727531A1 (is)
JP (1) JP2007528892A (is)
CN (1) CN1925849A (is)
AU (1) AU2004317129A1 (is)
BR (1) BRPI0418634A (is)
CA (1) CA2559493A1 (is)
CZ (1) CZ2006628A3 (is)
EA (1) EA200601666A1 (is)
HR (1) HRP20060326A2 (is)
IL (1) IL177735A0 (is)
IS (1) IS8547A (is)
MX (1) MXPA06010384A (is)
NO (1) NO20064644L (is)
RS (1) RS20060505A (is)
SK (1) SK50802006A3 (is)
WO (1) WO2005087212A1 (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク. 認知機能低下の阻害剤
CN104173336B (zh) * 2010-03-31 2018-02-02 重庆润泽医药有限公司 左旋奥拉西坦在制备预防或治疗认知功能障碍药物中的应用
SG192596A1 (en) 2011-02-02 2013-09-30 Cognition Therapeutics Inc Isolated compounds from turmeric oil and methods of use
ITGE20110050A1 (it) * 2011-04-29 2012-10-30 Marco Zipoli Alimento, in particolare una bevanda per l'alimentazione umana
BR112016017808B1 (pt) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc Composto ou sal farmaceuticamente aceitável, uso de um composto e composição para a inibição de um efeito betaamilóide numa célula neuronal
KR102614814B1 (ko) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 신경변성 질환 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
DE4136288A1 (de) * 1991-11-04 1993-05-06 Troponwerke Gmbh & Co Kg, 5000 Koeln, De Kombination von calciumantagonisten mit cholinesterase-inhibitoren
EP0813411B1 (en) * 1995-02-15 2002-01-23 Takeda Chemical Industries, Ltd. Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
GB9820489D0 (en) * 1998-09-22 1998-11-11 Steiger Malcolm J Compounds for improved treatment of parkinson's disease
US6426097B2 (en) * 2000-01-28 2002-07-30 Herbaceuticals Inc. Herbal supplement for cognitive related impairment due to estrogen loss
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
WO2002053147A1 (es) * 2000-12-29 2002-07-11 Osmotica Corp. Composicion farmaceutica para el tratamiento de la enfermedad cerebrovascular cognitiva
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
CA2459146A1 (en) * 2001-08-30 2003-03-13 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
DE20203244U1 (de) * 2002-03-01 2002-05-23 Meins, Wolfgang, Prof. Dr., 22391 Hamburg Pharmazeutische Zusammensetzung zur Prävention der Alzheimerdemenz
CN100337628C (zh) * 2002-08-07 2007-09-19 王登之 治疗痴呆症的尼莫地平口腔崩解片及其制备方法

Also Published As

Publication number Publication date
RS20060505A (en) 2008-09-29
CA2559493A1 (en) 2005-09-22
IL177735A0 (en) 2006-12-31
CN1925849A (zh) 2007-03-07
AU2004317129A1 (en) 2005-09-22
HRP20060326A2 (en) 2007-02-28
EA200601666A1 (ru) 2007-04-27
JP2007528892A (ja) 2007-10-18
US20080021016A1 (en) 2008-01-24
WO2005087212A1 (en) 2005-09-22
SK50802006A3 (sk) 2007-03-01
CZ2006628A3 (cs) 2007-01-24
BRPI0418634A (pt) 2007-05-29
NO20064644L (no) 2006-12-11
EP1727531A1 (en) 2006-12-06
MXPA06010384A (es) 2007-03-07

Similar Documents

Publication Publication Date Title
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DE602006007875D1 (de) Kapseln
NO20052027L (no) Katalysatorer
DE602007001870D1 (de) Eine bicyclische bisamidstruktur enthaltende pestizide
DK1816936T3 (da) Kapsel med tætningsmidler
DK1957073T3 (da) Lægemiddel
DE602005026188D1 (de) Medikamentenspender
DE602005012636D1 (de) Erung
ATE419193T1 (de) Verschlusskappe
DK1828148T3 (da) Triazolsubstituerede aminobenzophenonforbindelser
DK2338606T3 (da) Sprinklerenhed
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DK2918286T3 (da) En farmaceutisk formulering
IS8547A (is) Samsett lyfjablanda til að hamla gegn hrörnun vitsmunastarfsemi
DE502005001451D1 (de) Fugenabdeckprofil
DE602005000466D1 (de) Einwegverschlusskappe
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
DE602005010664D1 (de) Katalytische asymmetrische epoxydierung
AT500139B8 (de) Ringelement
FR2879415B1 (fr) Epingle a chignon
NO20045094L (no) Emballasje
FI20041361A (fi) Pakkausmateriaalit
DE112007000709A5 (de) Multifunktionelles Wirkstoffgemisch
DE112004001228A5 (de) Verschlusskappe
SE0400990D0 (sv) Läkemedel